Yoshino, T., Portnoy, D. C., Obermannová, R., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., García-Alfonso, P., Cohn, A. L., Van Cutsem, E., Yamazaki, K., Lonardi, S., Muro, K., Kim, T. W., Yamaguchi, K., Grothey, A., O'Connor, J., Taieb, J., Wijayawardana, S. R., Hozak, R. R., Nasroulah, F., & Tabernero, J. (2019). biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study. Annals of oncology, 30, 124–131. http://access.bl.uk/ark:/81055/vdc_100092353805.0x000033